Scientists from the University of Lausanne came to the conclusion that each type of female oncology requires not a general but a personal treatment approach. For the most effective treatment, researchers have created a special vaccine based on the body's acidic and immune cells, reports newscientist.com
Clinical studies of the preparation on women with severe ovarian diseases show that during 15 control weeks, the drug reduces the activity of the disease and, in combination with chemotherapy, allows the affected cells and parts of tissue to be "killed".
To prepare the composition for introduction into the body, researchers treat some of the affected cells or tissue samples with a special acid. It interacts with the diseased cells and creates a chemical reaction with the release of special molecules.
After the chemical reaction, the solution is "mixed" with the body's immune cells and injected back.
According to scientists, the survival rate of patients after this method is much higher: 80% of women who underwent complex therapy are alive and well after two years.